SCHEMBL208148

SCHEMBL208148

O=S(=O)(c1cccc(Nc2ccc(F)cc2)c1)N1CCCCC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
MAPT P10636 5/20 0.57
RXFP1 Q9HBX9 1/20 0.57
SMN1; SMN2 Q16637 4/20 0.56
HPGD P15428 2/20 0.56
POLB P06746 2/20 0.56
LMNA P02545 3/20 0.55
HTT P42858 2/20 0.55
MITF O75030 1/20 0.55
NOD2 Q9HC29 1/20 0.55
MAPK1 P28482 1/20 0.55
NPSR1 Q6W5P4 2/20 0.54
KDM4E B2RXH2 1/20 0.54
GAA P10253 1/20 0.54
RECQL P46063 1/20 0.54
THRB P10828 1/20 0.54
TSHR P16473 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208150 0.86 POLB (0.73) ALDH1A1MEN1KMT2AMAPTRXFP1
SCHEMBL208149 0.81 MAPT (0.54) ALDH1A1MEN1KMT2AL3MBTL1MAPT
SCHEMBL31684030 0.79 ALDH1A1 (0.67) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL28308929 0.79 ALDH1A1 (0.67) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL4555427 0.79 ALDH1A1 (0.67) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL1002168 0.79 SMN1; SMN2 (0.80) ALDH1A1MEN1KMT2AL3MBTL1MAPT
SCHEMBL28285201 0.79 ALDH1A1 (0.68) ALDH1A1MEN1KMT2AL3MBTL1MAPT
SCHEMBL12852518 0.79 ALDH1A1 (0.68) ALDH1A1MEN1KMT2AL3MBTL1MAPT
SCHEMBL14489550 0.78 ALDH1A1 (0.69) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL15612964 0.77 SMN1; SMN2 (0.78) ALDH1A1MEN1KMT2AL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 ALDH1A1 109/4885MEN1 3862/4885KMT2A 3476/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 ALDH1A1 109/4885MEN1 3862/4885KMT2A 3476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.